ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 176 filers reported holding ZAI LAB LTD in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $25,469,000 | -78.8% | 737,152 | -73.0% | 0.03% | -69.0% |
| Q1 2022 | $119,942,000 | -62.9% | 2,727,210 | -46.9% | 0.08% | -52.5% |
| Q4 2021 | $322,975,000 | -37.4% | 5,138,846 | +5.0% | 0.18% | -34.4% |
| Q3 2021 | $515,914,000 | -27.9% | 4,895,281 | +21.1% | 0.27% | -22.6% |
| Q2 2021 | $715,268,000 | +38.7% | 4,041,290 | +4.6% | 0.35% | +20.8% |
| Q1 2021 | $515,724,000 | -1.0% | 3,865,124 | +0.4% | 0.29% | -0.3% |
| Q4 2020 | $521,079,000 | +73.9% | 3,850,149 | +6.9% | 0.29% | +40.8% |
| Q3 2020 | $299,615,000 | +10.2% | 3,602,436 | +8.8% | 0.21% | -0.5% |
| Q2 2020 | $271,891,000 | +69.6% | 3,310,482 | +6.3% | 0.21% | +19.0% |
| Q1 2020 | $160,349,000 | +26.8% | 3,114,800 | +2.5% | 0.17% | +42.6% |
| Q4 2019 | $126,421,000 | +24.6% | 3,039,700 | -3.1% | 0.12% | +6.1% |
| Q3 2019 | $101,453,000 | +39.5% | 3,136,100 | +50.3% | 0.12% | +49.4% |
| Q2 2019 | $72,752,000 | +5674.0% | 2,086,383 | +4786.1% | 0.08% | +7600.0% |
| Q1 2019 | $1,260,000 | – | 42,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |